Prosecution Insights
Last updated: May 29, 2026
Application No. 18/484,584

SAFETY MECHANISM FOR AN AUTOINJECTOR

Non-Final OA §102
Filed
Oct 11, 2023
Priority
Jan 30, 2014 — EU 14153335.6 +3 more
Examiner
MEDWAY, SCOTT J
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Ypsomed AG
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
590 granted / 879 resolved
-2.9% vs TC avg
Strong +23% interview lift
Without
With
+23.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
33 currently pending
Career history
933
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
82.3%
+42.3% vs TC avg
§102
10.0%
-30.0% vs TC avg
§112
5.0%
-35.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 879 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement(s) filed on the record are in compliance with the content requirements of 37 CFR 1.97 and 37 CFR 1.98 and have been considered. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claim 1 is rejected on the ground of nonstatutory double patenting over claim 1 of U.S. Patent Nos. 10,894,127 and 11,813,434, since the claims, if allowed, would improperly extend the “right to exclude” already granted in the patent. The subject matter claimed in the instant application is fully disclosed in the patent and is covered by the patent since the patent and the application are claiming common subject matter, as follows: An autoinjector for dispensing a liquid product, comprising: a housing; a product container configured to hold the liquid product and arranged in the housing, the product container comprising a piston shiftable in a distal direction by a drive member for product dispensing; a covering cap removably arranged on a distal end of the housing; and a triggering member configured to protrude beyond the distal end of the housing in a starting position, wherein: when the covering cap is removed from the housing, the triggering member is movable in a proximal direction relative to the housing from the starting position into a triggering position for triggering product dispensing, and when the covering cap is arranged on the distal end of the housing, the triggering member is blocked against moving into the triggering position. Furthermore, there is no apparent reason why applicant was prevented from presenting claims corresponding to those of the instant application during prosecution of the application which matured into a patent. See In re Schneller, 397 F.2d 350, 158 USPQ 210 (CCPA 1968). See also MPEP § 804. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by inventor Vogt (WO 2010/136078 A1, hereinafter "Vogt"; see corresponding U.S. Pub. 2012/0203186 A1). Regarding claim 1, Vogt discloses an autoinjector for dispensing a liquid product, comprising: a housing 1 (Fig. 3a); a product container 5 (Fig. 3a) configured to hold the liquid product and arranged in the housing, the product container comprising a piston 5f (Fig. 3a) shiftable in a distal direction by a drive member for product dispensing; a covering cap 3 (Fig. 3a) removably arranged on a distal end of the housing; and a triggering member 2 (Fig. 3a) configured to protrude beyond the distal end of the housing in a starting position (Fig. 4a), wherein: when the covering cap 3 is removed from the housing, the triggering member is movable in a proximal direction relative to the housing from the starting position (Fig. 4a) into a triggering position (Fig. 5a) for triggering product dispensing, and when the covering cap 3 is arranged on the distal end of the housing (as shown in Fig. 4a), the triggering member 2a is blocked against moving into the triggering position (by way of the spring-mounted barring means deflectable by the covering cap 3 into a barring position; the barring position corresponds to the barring means 2a being biased radially outward by the force of the holding portion 3c of the cap 3 in which the barring means 2a face the stop 1b, and so when the cap 3 is on the housing in the starting position, a holding portion 3c of the cap blocks the triggering member 2 from moving inwardly into its triggering position by biasing the barring means 2a outwardly into facing contact with the stop 1b). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See Notice of References Cited. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SCOTT J MEDWAY whose telephone number is (571)270-3656. The examiner can normally be reached Monday through Friday, 8:30 AM to 5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at (571) 270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SCOTT J MEDWAY/Primary Examiner, Art Unit 3783 02/13/2026
Read full office action

Prosecution Timeline

Oct 11, 2023
Application Filed
Mar 02, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636483
SEALING MEMBER
7y 3m to grant Granted May 26, 2026
Patent 12636431
DRUG DELIVERY INSERTION APPARATUSES AND SYSTEM
2y 1m to grant Granted May 26, 2026
Patent 12623021
MEDICAMENT DELIVERY DEVICE COMPONENT
3y 9m to grant Granted May 12, 2026
Patent 12611328
OPHTHALMOSURGICAL APPLIANCE
4y 0m to grant Granted Apr 28, 2026
Patent 12611267
DEVICE DRIVE FOR CATHETER PROCEDURE SYSTEM
3y 6m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
90%
With Interview (+23.2%)
3y 8m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 879 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month